$42.17
0.441.05%
At close: -
$42.17
0.000.00%
After Hours: 1:00 PM EDT
Comments
Loading...
Mirum Pharmaceuticals (MIRM) Forecast
NewsEarningsMirum Pharmaceuticals (MIRM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMirum Pharmaceuticals (NASDAQ:MIRM) Stock Quotes, Forecast and News Summary
Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mirum Pharmaceuticals (MIRM) stock?
You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.
Who are Mirum Pharmaceuticals (MIRM) competitors?
Other companies in Mirum Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Mirum Pharmaceuticals (MIRM) stock?
Mirum Pharmaceuticals has a consensus price target of $55.87.
What is the current price for Mirum Pharmaceuticals (MIRM)?
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $42.17 last updated December 24, 2024 at 1:00 PM EST.
Does Mirum Pharmaceuticals (MIRM) pay a dividend?
There are no upcoming dividends for Mirum Pharmaceuticals.
When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?
Mirum Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Mirum Pharmaceuticals (MIRM) going to split?
There is no upcoming split for Mirum Pharmaceuticals.
What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.